CAPN1 is a novel biomaker of patients with AML based on comprehensive analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CAPN1 is a novel biomaker of patients with AML based on comprehensive analysis

Published:2023-04-28 Issue: Volume: Page:1-17
ISSN:0264-8725
Container-title:Biotechnology and Genetic Engineering Reviews
language:en
Short-container-title:Biotechnology and Genetic Engineering Reviews

Author:

Wang Houcai¹,Ma Ruye¹,Gu Jianbang²,Chen Pan¹,Wang Yuwen¹,Wei Rong¹

Affiliation:

1. Department of Hematology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China

2. Department of Hematology and Neurology, Shanghai Tenth People’s Hospital Chongming Branch, Tongji University School of Medicine, Shanghai, China

Funder

no funding

Publisher

Informa UK Limited

Subject

Molecular Biology,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02648725.2023.2204688

Reference22 articles.

1. The cytokine network in acute myeloid leukemia (AML): A focus on pro- and anti-inflammatory mediators

2. The Role of Metabolism in the Development of Personalized Therapies in Acute Myeloid Leukemia

3. Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal

4. Management of Acute Myeloid Leukemia: Current Treatment Options and Future Perspectives

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP